Pharming Group N.V. (PHAR) Reports In-Line Q2 EPS

Pharming Group N.V. (NASDAQ: PHAR) reported Q2 EPS of $0.00, in-line with the analyst estimate of $0.00. Revenue for the quarter came in at $74.1 million versus the consensus estimate of $71.94 million.

For earnings history and earnings-related data on Pharming Group N.V. (PHAR) click here.

You May Also Be Interested In

• UBS Starts Kalyan Jewellers India Ltd (KALYANKJ:IN) at Buy
• Northrop Grumman wins two U.S. defense contracts worth $38.7m
• 37 Capital raises $300,000 in partial private placement closing